about
Best hope or last hope: access to phase III clinical trials of HER-2/neu for advanced stage breast cancer patients.Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemiaRandomized phase II trials: a long-term investment with promising returnsRandomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer.Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder CancerRandomized phase II designs.Randomized phase II study of sequential carboplatin plus paclitaxel and gefitinib in chemotherapy-naïve patients with advanced or metastatic non-small-cell lung cancer: Long-term follow-up resultsCisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part).Phase II clinical trials in oncology: are we hitting the target?Alternative designs for clinical trials in rare diseases.Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluation.
P2860
Q33836107-6DD4BB45-85A4-437C-83AC-30B259FA5087Q34488787-A16FA5CD-445D-4E9D-A67E-306D9C303003Q34790388-20CFE712-6724-4CF8-88C5-11496112D10CQ35115259-04CF1E3F-DBC2-4BFF-B740-245A0BD9BAE4Q36484581-6FF92253-DE2B-47E3-B16A-00DEABE554D7Q37053820-13D2BE46-2790-424E-9520-C7DC36B59396Q37173942-81110BC6-F61E-4E48-97C7-344D414594DEQ37594039-57DAABD0-61B0-4F03-BDDC-A4BF3CAA11B3Q37600501-A3FE8C5F-37F7-42ED-B91A-22D2F47D24C6Q37705422-3C8AD966-72F7-4CE8-B473-82BE626D1CD2Q39013156-A253FBD9-9883-4E4C-ABFC-7B3EB2C769FFQ46103183-2EEFC57C-30F5-42FF-A99C-45C9987C7E29
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Selection designs for pilot studies based on survival.
@en
Selection designs for pilot studies based on survival.
@nl
type
label
Selection designs for pilot studies based on survival.
@en
Selection designs for pilot studies based on survival.
@nl
prefLabel
Selection designs for pilot studies based on survival.
@en
Selection designs for pilot studies based on survival.
@nl
P2093
P356
P1433
P1476
Selection designs for pilot studies based on survival.
@en
P2093
P304
P356
10.2307/2532552
P407
P577
1993-06-01T00:00:00Z